Your browser doesn't support javascript.
loading
Neutrophil-to-lymphocyte ratio trend: A novel prognostic predictor in patients with nasopharyngeal carcinoma receiving radiotherapy.
Yang, Pei; Zhao, Yu; Liang, Hao; Zhou, Guanzhi; Youssef, Bassem; Elhalawani, Hesham; Li, Meizhen; Tan, Fengbo; Jin, Yi; Jin, Hekun; Zhu, Hong; Mohamed, Abdallah Sherif Radwan; Chonnipa, Nantavithya; Kannarunimit, Danita; Shi, Yingrui; Wang, Hui; Fuller, Clifton David.
Affiliation
  • Yang P; Xiangya Hospital, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Zhao Y; Key Laboratory of Translational Radiation Oncology, 117924Hunan Cancer Hospital, the Affiliate Hospital of Xiangya Medical School, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Liang H; Key Laboratory of Translational Radiation Oncology, 117924Hunan Cancer Hospital, the Affiliate Hospital of Xiangya Medical School, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Zhou G; The Miriam Hospital, Providence, RI, USA.
  • Youssef B; Institute of TCM Diagnostics, 118393Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
  • Elhalawani H; Key Laboratory of Translational Radiation Oncology, 117924Hunan Cancer Hospital, the Affiliate Hospital of Xiangya Medical School, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Li M; University of South China, Hengyang, Hunan, People's Republic of China.
  • Tan F; Department of Radiation Oncology, 11238American University of Beirut, Beirut, Lebanon, Lebanon.
  • Jin Y; Department of Radiation Oncology, 2569Cleveland Clinic, Cleveland, OH, USA.
  • Jin H; Research Institute of Drug Metabolism and Pharmacokinetics, 159374Xiangya School of Pharmaceutical Sciences, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Zhu H; Xiangya Hospital, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Mohamed ASR; Key Laboratory of Translational Radiation Oncology, 117924Hunan Cancer Hospital, the Affiliate Hospital of Xiangya Medical School, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Chonnipa N; Key Laboratory of Translational Radiation Oncology, 117924Hunan Cancer Hospital, the Affiliate Hospital of Xiangya Medical School, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Kannarunimit D; Xiangya Hospital, 506618Central South University, Changsha, Hunan, People's Republic of China.
  • Shi Y; Department of Radiation Oncology, 4002MD Anderson Cancer Center, Houston, TX, USA.
  • Wang H; Department of Medicine, 26683Chulalongkorn University/King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Fuller CD; Department of Medicine, 26683Chulalongkorn University/King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Int J Biol Markers ; 37(3): 270-279, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35775111

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Neutrophils Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Biol Markers Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Neutrophils Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Biol Markers Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States